The global — Research Antibodies and Reagents Market will grow at a CAGR of 6.5% from 2018 to reach USD 13,276.5 million by 2023. This growth is mainly attributed to “rising proteomics & genomic research studies, increase in the funding for research activities, and growing industry-academia collaborations. In addition to these factors, the opportunities like growing demand for protein therapeutics & personalized medicines, rising investment & focus on the area of stem cell research, need for new biomarker identification, and emerging regional markets like Asia-Pacific and Latin America, ensures the positive growth of this market in near future”, Meticulous Research™ noted in a press release today.
The report also analyses the restraining factors in this market such as “issues related to quality and stability of research antibodies such as cross-reactivity and storage conditions, and intense pricing pressure on the leading players”.
Read more below, or download now : https://www.meticulousresearch.com/download-sample-report/?cp_id=3642
The report also notes that, on the basis of product type, reagents commanded the largest share of in the global research antibodies and reagents market in 2017. This is primarily attributed to the huge demand for various reagents in many routine assays and techniques with increasing focus on understanding molecular basis of diseases and routine use in target based assays during the basic research.
While on the basis of technology, western blotting held the largest share in the global research antibodies and reagents market in 2017. This was mainly attributed to increasing focus on biomedical research for initiating developments in diagnosis and therapy, rising funding for biomarker discovery, and raising demand for antibody & cell-based research and subsequent adoption of this technology in these research studies due to their high sensitivity & specificity to quantify the very low levels of proteins in the sample.
On the basis of application, proteomics held the largest share in the global research antibodies and reagents market in 2017. This was mainly attributed to rising uptake of research antibodies in the significantly growing proteomics market. The upsurge in proteomics research is attributed to the rising need for designing more effective drugs through protein-based disease profiling, growing demand for personalized & protein therapeutics, and increasing public & private sector spending on proteomics research.
In terms of end users, pharmaceutical and biotechnology industry commanded the largest share in 2017, due to the rising adoption of research antibodies & reagents in the proteomics research and drug discovery and development with the growing focus of industry vendors on innovating therapeutics for various chronic diseases.
Geographically, Meticulous Research™ has segmented this market into North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, and RoE), Asia Pacific (Japan, China, India, and RoAPAC), Latin America, and Middle East & Africa. Wherein, North America region is expected to dominate the global research antibodies and reagents market with maximum percentage of shares in 2017, followed by Europe and Asia-Pacific. This is mainly due to remarkably advanced healthcare industry with higher healthcare spending and adoption of innovative science & technology, increasing prevalence of chronic and rare diseases, and presence of leading players in the market in this region.
The key players analyzed in the global Research Antibodies and Reagents Market are GE Healthcare (U.S.), Merck & Co., Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Amgen Inc. (U.S.), Sanofi (France), F. Hoffmann La-Roche Ltd (Switzerland), Rockland Immunochemicals Inc. (U.S.), Johnson & Johnson (U.S.), Agilent Technologies, Inc. (U.S.), Eli Lilly and Company (U.S.), Becton Dickinson and Company (U.S.), Danaher Corporation (U.S.), PerkinElmer, Inc. (U.S.), GenScript Biotech Corporation (U.S.), Lonza (Switzerland), Bio-Techne Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Teva Pharmaceutical Industries Limited (Israel), Santa Cruz Biotechnology, Inc. (U.S.), BioLegend, Inc. (U.S.), Abcam PLC (U.K.), and Cell Signaling Technology, Inc. (U.S.).
Browse in-depth Report on https://www.meticulousresearch.com/product/research-antibodies-reagents-market-2023/
Key Topics Covered in This Report:
2. Research Methodology
3. Executive Summary
4. Market Insights
4.1. Market Dynamics
5. Research Antibodies and Reagents Market, by Product
6. Research Antibodies and Reagents Market, by Technology
7. Research Antibodies and Reagents Market, by Application
8. Research Antibodies and Reagents Market, by End Users
8.1. Pharmaceutical & Biotechnology Industry
8.2. Academic & Research Institutes
8.3. Contract Research Organizations
9. Research Antibodies and Reagents Market, by Geography
9.1. North America
9.4. Rest of the World
9.5. Latin America
9.6. Middle East & Africa
10. Competitive Landscape
11. Company Profiles (Business Overview, Financial Overview, Product Portfolio, and Strategic Developments)
Enquire before buying: https://www.meticulousresearch.com/enquire-before-buying/
Browse more Related Report:
High Throughput Screening Market Size by Products & Services (Consumables & Reagents, Instruments, Software & Services), by Application (Stem Cell Research, Toxicology Assessment, Primary Screening, Target Identification), by End-User (Pharmaceuticals and Biotechnology Industries, Academics and Research Institutes, Contract Research Organizations, and Others) – Global Opportunity Analysis and Industry Forecasts To 2022
Browse report: https://www.meticulousresearch.com/product/high-throughput-screening-market-forecast/
Clinical Genomics Market by Test Type (Diagnostic, Genetic, Newborn Screening, Prenatal, Carrier Screening), Software, Method (Molecular, Chromosomal, Biochemical Tests), End User (Hospitals & Clinics) – Global Opportunity Analysis And Industry Forecast To 2023
Browse report: https://www.meticulousresearch.com/product/clinical-genomics-market-forecast-2023/
Name: Viren Shrivastava
Email: Send Email
Organization: Meticulous Market Research Pvt. Ltd.
Address: Wembley, Middlesex- HA0 4JH, U.K.
Release ID: 400048